Polymorphism detection of K-Ras mutations using high-resolution melting analysis in Mexican patients with metastatic colorectal cancer (mCRC)

被引:0
|
作者
Astudillo, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Sanchez-Guillen, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Romero-Garcia, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Bastarrachea-Ortiz, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Morgan-Villela, G. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Salazar, J. M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Vazquez-Rivera, V. M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Ruiz-Calzada, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Cortes-Esteban, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] HC CMN SXXI, IMSS, UIMEM, Lab Res Traslac, Mexico City, DF, Mexico
[2] Hosp Gen Zona 25, IMSS, Monterrey, NL, Mexico
[3] CMO, IMSS, Guadalajara, Jalisco, Mexico
[4] Opcion Oncolog, Monterrey, Mexico
[5] Torre Med Sur, Mexico City, DF, Mexico
[6] Hosp Reg, ISSSTE, Zacatecas, Zacatecas, Mexico
[7] CMN 20 Noviembre, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15135
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Differential High-Resolution Melting Analysis for the Detection of K-ras Codons 12 and 13 Mutations in Pancreatic Cancer
    Zhang, Chunyan
    Guo, Wei
    Wu, Jiong
    Song, Binbin
    Zhang, Chen
    Dai, Qian
    Pan, Baishen
    Ji, Yuan
    Guo, Jinghui
    PANCREAS, 2011, 40 (08) : 1283 - 1288
  • [2] Role of EGFR, DCC and K-RAS mutations in metastatic colorectal cancer (mCRC) patients treated with cetuximab
    Mancuso, A.
    Leone, A.
    Cerbone, L.
    Zivi, A.
    Squilloni, E.
    Bertagnolio, F.
    Caristo, R.
    Gasbarra, R.
    Roberto, P.
    Sternberg, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 39 - 39
  • [3] Frequency of K-ras mutations in patients with colorectal cancer in a Mexican population
    Martinez-Garza, SG
    Nunez-Salazar, AJ
    Calderon-Garciduenas, AL
    Bosques-Padilla, FJ
    Niderhauser-Garcia, A
    Barrera-Saldana, HA
    GASTROENTEROLOGY, 1999, 116 (04) : A459 - A459
  • [4] Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis
    Ma, E. S. K.
    Wong, C. L. P.
    Law, F. B. F.
    Chan, W-K
    Siu, D.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (10) : 886 - 891
  • [5] Analysis of K-ras mutations in the stool of patients with colorectal cancer
    Pagani, R
    Porcelli, B
    Forsi, B
    Civitelli, S
    Mancini, A
    Civitelli, B
    Tanzini, G
    Marinello, E
    MINERVA BIOTECNOLOGICA, 1996, 8 (03) : 142 - 144
  • [6] High-resolution melting analysis (HRMA) for KRAS mutational study in patients with metastatic colorectal cancer (mCRC pts).
    De Stefano, Alfonso
    Malapelle, Umberto
    Carlomagno, Chiara
    Bianco, Roberto
    Marciano, Roberta
    Cimminiello, Carolina
    Colantuoni, Maria
    De Placido, Sabino
    Troncone, Giancarlo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] EGFR, DCC, and K-RAS mutations as predictive factors for cetuximab sensitivity in metastatic colorectal cancer (mCRC)
    Mancuso, A.
    Leone, A.
    Vigna, L.
    Calabro, F.
    Giuliani, R.
    De Marco, S.
    D'Alessio, A.
    Gasbarra, R.
    Pisa, R.
    Sternberg, C. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Detection of APC and k-ras mutations in the serum of patients with colorectal cancer
    Lauschke, H
    Caspari, R
    Friedl, W
    Schwarz, B
    Mathiak, M
    Propping, P
    Hirner, A
    CANCER DETECTION AND PREVENTION, 2001, 25 (01): : 55 - 61
  • [9] Future Solutions for Patients with Metastatic Colorectal Cancer Positive for K-RAS Mutations
    Capareli-Azevedo, Fernanda
    Riechelmann, Rachel P.
    Hoff, Paulo M.
    CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 275 - 280
  • [10] Timing of testing for K-ras mutational status in metastatic colorectal cancer (mCRC).
    Corral, Mitra
    Sotak, Michelle
    Chastek, Benjamin
    Penrod, John R.
    Cairns, Jessica
    Williams, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)